Optimizing Mesalamine Strategies
By Ellen J. Scherl, MD; Arun Swaminath, MD; Brian Bosworth, MD; Vinita Jacob, MD; Dana J. Lukin, MD, PhD
The greatest challenge for clinicians who treat patients with IBD is to move from symptom-oriented (step-up) strategies toward prevention-oriented (early intervention) strategies. This review focuses on a personalized approach to the treatment of IBD using 5-ASA agents.
Download to read this article in PDF document:
This article is in PDF format and it requires Abobe Reader. If you do not have Adobe Reader installed on your computer then please download and install from the link below.